125 related articles for article (PubMed ID: 37419277)
1. Depleted hexokinase1 and lack of AMPKα activation favor OXPHOS-dependent energetics in retinoblastoma tumors.
Babu VS; Mallipatna A; Dudeja G; Shetty R; Nair AP; Tun SBB; Ho CEH; Chaurasia SS; Bhattacharya SS; Verma NK; Lakshminarayanan R; Guha N; Heymans S; Barathi VA; Ghosh A
Transl Res; 2023 Nov; 261():41-56. PubMed ID: 37419277
[TBL] [Abstract][Full Text] [Related]
2. Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels.
Suresh Babu V; Dudeja G; Sa D; Bisht A; Shetty R; Heymans S; Guha N; Ghosh A
Cells; 2022 Oct; 11(20):. PubMed ID: 36291051
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors.
Babu VS; Mallipatna A; Sa D; Dudeja G; Kannan R; Shetty R; Nair AP; Gundimeda S; Chaurasia SS; Verma NK; Lakshminarayanan R; Heymans S; Barathi VA; Guha N; Ghosh A
Cells; 2022 May; 11(10):. PubMed ID: 35626705
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
5. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
[TBL] [Abstract][Full Text] [Related]
6. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
Singh HP; Wang S; Stachelek K; Lee S; Reid MW; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9391-E9400. PubMed ID: 30213853
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
Wu S; Ai N; Liu Q; Zhang J
Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104
[TBL] [Abstract][Full Text] [Related]
8. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
10. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
11. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
12. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
[TBL] [Abstract][Full Text] [Related]
13. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
[TBL] [Abstract][Full Text] [Related]
14. Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.
Allaman-Pillet N; Oberson A; Schorderet DF
Oncotarget; 2017 Feb; 8(9):15490-15506. PubMed ID: 28099942
[TBL] [Abstract][Full Text] [Related]
15. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
[TBL] [Abstract][Full Text] [Related]
16. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
17. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
[TBL] [Abstract][Full Text] [Related]
18. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
[TBL] [Abstract][Full Text] [Related]
20. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway.
Yu B; Zhao J; Dong Y
Curr Eye Res; 2021 Sep; 46(9):1414-1423. PubMed ID: 33629639
[No Abstract] [Full Text] [Related]
[Next] [New Search]